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Background and aims: Breast cancer is one of the main causes of death in women, the early diagnosis of which is made by physical 
examination, mammography, ultrasound, and biopsy of breast masses. The aim of this study was to assess the diagnostic accuracy of fine 
needle aspiration (FNA) compared to core needle biopsy (CNB) in breast masses.
Methods: The current descriptive study was conducted in Kashani and Hajar hospitals in 2015. And a total of 200 patients diagnosed with 
breast masses participated in this study. First, patients referred to the clinic, received local anesthesia in the area, and then underwent FNA 
using 10 cc syringes and 23G needles, and simultaneously CNB specimens were taken by a special needle for diagnosis. FNA and CNB 
specimens were transferred to the Pathology Department with a few day interval for cytological interpretation.
Results: The sensitivity and specificity of FNA compared to CNB in the diagnosis of malignant breast masses were 83.9% and 89.9%, 
respectively. Moreover, the positive and negative predictive values of FNA for breast masses were 78.8% and 92.5%, respectively. The 
accuracy of FNA test for breast masses was also 0.88%.
Conclusion: According to the results of this study, FNA test had a high sensitivity, specificity, and predictive value in the diagnosis of breast 
masses. Therefore, it could be used as an appropriate diagnostic tool, and could obviously save many costs as well.
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Introduction 
Breast cancer is one of the most common malignancies 
in today’s societies (1) and one of the leading causes of 
death among women, the early diagnosis of which is an 
important factor in reducing female mortality (2,3). In 
addition, breast cancer is the leading cancer in women and 
accounts for 25.4% of all malignancies (4). Diagnosis of 
breast cancer is made by means of clinical examination, 
mammography, ultrasound, and biopsy of the breast mass. 
Mammography is one of the most common non-
invasive methods, which is used for breast examination, 
and has diagnostic value in both screening and detecting 
the disease cases. Another non-invasive technique used 
for breast examination, especially for dense breasts, is 
ultrasound (5). The value of ultrasound in studies has been 
reported to be 70%-90% (6-8). Further, breast biopsy is the 
most common and definitive diagnostic method of breast 
cancer. About 1 800 000 breast biopsies are reportedly 
taken each year in the United States, approximately 70%-
80% of which are related to benign breast masses (9,10). 
Fine needle aspiration (FNA), core needle biopsy (CNB), 
and excisional biopsy are among the methods that are 
used for diagnosis of breast masses (11,12). Most of the 
malignant masses are diagnosed by the cytology of FNA or 
CNB before surgery, and definitive surgical treatment can 
be scheduled accordingly (13). FNA is one of the common 
tests used for the diagnosis of breast masses, whose 
success rate and diagnostic accuracy depends on physical 
examination and radiological studies, especially in small 
and impalpable masses (14,15). It is a fast test, but not in 
the first line of screening. If this test is conducted under 
ultrasound or mammography guidelines, it will have a 
high sensitivity and specificity. This test causes very few 
complications and, in rare cases, seeding or implantation 
may occur in the needle path (16,17). Pathologists report 
that the diagnosis of breast cancer using FNA-derived 
tissue and cells is much easier and more convenient 
(18). In fact, FNA can make over 30% of non-definitive 
diagnoses, 20% of defective diagnoses, and over 10% of 
suspicious diagnoses, but does not diagnose malignancies 
(19). However, this method has some limitations, 
including difficulty in making a diagnosis of an in-situ, 
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invasive cancer. In the case of tiny tumors, it also has low 
diagnostic accuracy (15). 
On the contrary, CNB has a higher sensitivity than 
FNA and, if it is image-guided, its sensitivity will increase 
from 86% to 98%. Over the past decades, CNB has been 
used more frequently than FNA for the diagnosis of breast 
masses (18), and it has been preferred to FNA (20,21); 
even some researchers have argued that the use of FNA 
should be abandoned (22). A large body of research on 
the determination of the diagnostic value of FNA in 
breast masses have reported its sensitivity and specificity 
as 90%-100%, and its predictive value as 95%-100%. In 
addition, its positive and negative predictive values have 
been reported to be 95%-100%. The false-positive and 
false-negative rates of the test are also between 1%-10% 
and often 1%-5% (23-25). CNB comparatively causes 
more complications, mainly including pain and bleeding; 
particularly, in the women who use anticoagulants such 
as heparin or warfarin, the risk of bleeding is higher. 
Moreover, the risk of pneumothorax in CNB is about 1% 
(16). CNB is a costly method and has been reported to 
be an inappropriate strategy due to failure in making an 
early diagnosis before surgery. It is also argued that the 
accuracy of this method is influenced by the operator’s 
technical skills as well as the numbers and sizes of 
the samples taken. Although FNA accuracy is largely 
influenced by the operator’s skill, it is faster, more cost-
effective, and less invasive, and causes fewer complications 
(26,27). In the study of Mohajeri et al, FNA was observed 
to have sensitivity and specificity of 84.8% and 94.4%, 
respectively, in comparison with the CNB. The positive 
predictive value of the FNA test was 95.1% and its negative 
predictive value was 82.9% (28). 
Taken together, with regard to the abovementioned 
material and the results of the previous studies, there is still 
doubts and controversies about which of the two sampling 
methods should be considered a diagnostic test for breast 
cancer (29,30). In addition, various results regarding the 
sensitivity, specificity, and accuracy of FNA and CNB have 
been reported from different laboratories with reportedly 
various causes, including the skill of the aspiration and 
biopsy performer and the experience of the person who 
reports the results (31). Therefore, this study aimed to 
investigate the diagnostic accuracy of FNA compared to 
CNB in breast masses.
Materials and Methods
This study was conducted on the patients with breast 
masses in Kashani and Hajar hospitals of Shahrekord, 
Iran, in 2015.
Sample size was determined to be 196 using the following 
formula, with regard to the similar studies, assuming that 
the FNA and CNB diagnostic test index was at least 85%, 
a confidence interval of 95%, and an accuracy of five-fold 










Women with negative (benign) and positive (malignant 
or suspicious) masses who had unspecified diagnosis were 
included in the study, while those who had undergone 
chemotherapy were excluded. Furthermore, lack of 
knowledge of the final outcome of the masses, lack of 
continuing the participation, or lack of compatibility of 
the pathology report with the purpose of the study were 
other exclusion criteria. 
During the study, all the patients initially referred for 
FNA and CNB completed the informed written consent 
forms, and then were diagnosed by imaging methods and 
referred for FNA and CNB. 
In general, the FNA is used to make an immediate 
diagnosis of a lesion, and the CNB is performed to make a 
definitive diagnosis and to determine prognosis. 
In this study, patients referred to the clinic, first 
received local anesthesia in the area, and then underwent 
FNA test using 10 cc syringes and 23G needles, and 
simultaneously CNB specimens were taken using a special 
needle for diagnosis. CNB specimens were transferred to 
the Pathology Department for pathological interpretation.
From the FNA aspirates, 4 slides were prepared and 
fixed in 96% ethanol. All the slides were numbered and 
recorded anonymously. The prepared FNA and CNB slides 
were transferred to the Pathology Department with a few 
day interval for cytological interpretation, and interpreted 
by two pathologists. All the data were recorded in the 
checklists. Using the data, positive and negative predictive 
values, sensitivity and specificity, and false-negative 
and false-positive rates of FNA for breast masses were 
calculated. The checklist included individual and clinical 
items (age, type of operation, tumor direction, number of 
children, oral contraceptive pill taking, lactation, familial 
history, and first menstrual period), FNA result, CNB 
result, and pathology report on breast masses. 
The data were encoded and entered into the SPSS 
software version 22.0. Statistical analysis was performed 
by descriptive statistics (frequency, mean, and standard 
deviation) and inferential statistics (chi-square) to compare 
FNA and CNB.
Results
A total of 200 patients aged 14 to 89 years old (mean age: 
40.08 ± 14.60) were studied. Only 1 patient was male. 
Forty-three of the patients (21.5%) had no children and 
the rest of the patients had at least 1 and at most 11 
children (mean: 2.59 ± 2.10). In 103 cases (51.5%), the 
masses were on the right side and in the rest, the masses 
were on the left side. No binary masses were observed. 
Out of 200 participants, 50 cases were under modified 
radical mastectomy and 150 patients underwent mass 
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excision. Regarding the use of oral contraceptive pills, 59 
patients (29.5%) took contraceptive pills for 0.5-14 years 
(mean: 1.13 ± 2.27). Considering the family history of 
cancer, 25 patients (12.5%) had such a history. Regarding 
breastfeeding, most women (74.5%) reported having 
breastfeeding. In our participants, the mean age at first 
menstruation was 12.21 ± 1.58 years (range: 9-18).
The FNA results of breast masses were negative for 134 
patients (67%), positive for 38 (19%), and suspicious for 
28 (14%). In addition, the CNB results of breast masses 
were benign for 138 patients (69%), consisting of 7 cases 
of inflammation, 100 cases of fibroadenoma, 2 cases of 
duct ectasia of the breast, 25 cases of fibrocystic breast 
disease, and 4 cases of benign lesions; and malignant 
for 62 (31%) consisting of 60 cases of invasive ductal 
carcinoma, 1 case of invasive atypical ductal hyperplasia, 
and 1 case of phyllodes tumor. The frequency distribution 
of the FNA test results versus the CNB test showed that 
suspicious FNA results were positive (Table 1, Figure 1). 
The sensitivity of the FNA test was 83.9% in comparison 
with the CNB test for malignant breast masses (Table 1). 
In other words, for the 62 patients diagnosed with 
malignant tumors in the CNB test, the FNA test result was 
malignant for 52 of them. In addition, this test detected 
124 of the 138 benign masses as benign. Therefore, the 
FNA test had a specificity of 89.9% in comparison with 
the CNB test for benign breast masses. On the other 
hand, in the FNA test, 10 cases of the malignant masses 
were detected as benign and 14 cases of benign masses as 
malignant. Therefore, this test had a false-negative rate of 
16.1% and a false-positive rate of 10.1%.
Based on the results, of 66 patients diagnosed with 
malignant masses by FNA test, 62 were really malignant, 
so the positive predictive value of FNA for breast mass was 
78.8%. Of the 138 cases diagnosed with benign masses 
by FNA, 134 cases were benign, so the negative predictive 
value of FNA for breast mass was 92.5%. The accuracy of 
FNA test for breast mass in our participants was 0.88%.
Discussion
Breast cancer is the most common type of cancer in 
women, so it is obviously logical to consider the need 
for a simple and inexpensive method that could detect 
malignant lesions from benign ones. The main purpose 
of this study was to determine the accuracy of diagnosis 
made by FNA in comparison with CNB in breast masses. 
The results of our study showed that the FNA test had 
a sensitivity of 83.9% and a specificity of 89.9% for the 
detection of breast masses in comparison with the CNB 
test.
Previous studies have shown that FNA test is more 
convenient and faster, has less bleeding risk, is more cost-
effective, causes especially less stress in the patient, and if 
it has a high diagnostic value, it can be used to diagnose 
malignancies in breast masses (28). In this study, in the 
diagnosis of breast masses, false-negative result was 16.1% 
and false-positive result was 10.1%, which are within 
the range of global statistics (3%-27%) and acceptable 
(5,33). In the study of Mohajeri et al, the FNA test, in 
comparison with CNB, had a sensitivity of 48.8% and a 
specificity of 94.4% for diagnosis of breast tumors; and 
for breast masses larger than 1 cm, a sensitivity of 76.5% 
and a specificity of 100% was observed. In this study, FNA 
was 15.2% false-negative and 5.6% false-positive (28). In 
the study of Nakano et al, the false-positive and false-
negative rates of FNA results for small breast lesions were 
16.7% and 3.4%, respectively (34). It is argued that one 
of the important reasons for false-negative FNA results is 
taking inadequate specimens. If the FNA is performed by 
a qualified physician and the cytology is performed by a 
qualified pathologist using the triple test (mammography, 
ultrasound, and FNA), it will be definitely more sensitive 
(35). In our study, the positive predictive value of FNA test 
for the masses was 78.8% and the negative predictive value 
was 92.5%. In the study of Mohajeri et al, the positive and 
negative predictive values of FNA test were 95.1% and 
82.9%, respectively, while the FNA test accuracy was 89% 
(28). In our study, the accuracy of FNA test for breast mass 
was obtained 0.88%.













Total (N) 138 62 200
Row percentage 69% 31% 100%
Column percentage 100% 100% 100%
Figure 1. ROC curve analysis in evaluating the diagnostic accuracy of FNA 
in breast masses.
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In the study of Moschetta et al, sensitivity, specificity, 
diagnostic accuracy, and positive and negative predictive 
values were 97%, 94%, 95%, and 91% and 98% for 
FNA, and 92%, 82%, 89%, and 92% and 82% for 
CNB, respectively, compared to the pathology report. The 
authors concluded that both FNA and CNB had similar 
diagnostic accuracies in detecting breast lesions (36).
In the study of Nassar, ultrasound-guided FNA was 
found to be a useful method with high sensitivity and 
specificity for the diagnosis of breast masses, and therefore 
could even replace more invasive methods such as CNB 
(17). 
In one study, the accuracy of FNA was investigated in 
128 cases of palpable breast masses. The findings showed 
that FNA had a sensitivity of 91%, a specificity of 97%, a 
positive predictive value of 97%, and a negative predictive 
value of 90% for diagnosis of the masses. It is argued that 
the technical skill in taking an FNA specimen, as well as 
coordination between the endocrinologist, surgeon, and 
pathologist play a major role in the diagnostic value of this 
method (37). Unlike our findings, in the study of Pagni 
et al, the CNB test was far superior to the FNA cytology, 
and it was argued that given that the cytology of FNA is 
less costly than CNB, its accuracy is lower (78% versus 
93%) and is less used (32). In another study, the sensitivity 
and specificity for FNA were 72.5% and 100%, and the 
positive and negative predictive values were 81.7% and 
100%, respectively. The study showed that CNB was more 
sensitive than FNA for the patients with newly diagnosed 
invasive breast cancer (38). 
The predictive value is one of the most important 
indicators of a diagnostic test. For example, the negative 
predictive value (indicating the possibility of not being 
patient when the test result is negative) should be so high 
that the physician could safely rely on it and be able to 
surely reject the malignancy in the patient. On the contrary, 
the positive predictive value (indicating the possibility of 
not being patient when the test result is positive) also is 
highly valuable in the malignancies and the doctor can 
make a diagnosis of malignancy if the result of the test is 
absolutely strong (28). For patients diagnosed with cancer, 
appropriate planning leads to an effective treatment, 
as well as educating the patients about the appropriate 
therapeutic options (37).
Conclusion
Considering the high success rate of FNA test in breast 
masses and few false negative results, it seems that even 
fewer negative false values could be obtained with more 
skilled surgeons and pathologists. Therefore, FNA is 
recommended in breast cancer cases, and given that the 
test can also be performed on outpatients, it seems that it 
is more cost-effective than the CNB test. In addition, since 
it does not require special equipment and can be easily 
done by different physicians with brief training, it causes 
minimal complications, and is more tolerable for patients. 
Further, it can be easily and routinely done and can be 
used in most cases as an alternative method for CNB for 
diagnosis of breast masses, if sampling and preparation 
of the samples and the pathological interpretation are 
conducted in a sufficiently accurate manner.
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